Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Defense
- Branch
- Office for Chemical and Biological Defense
- Recipient company
- PHYSICAL SCIENCES INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- RMG1AZ1ZH8Q7
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Physical Sciences Inc. proposes to develop a robust field-deployable assay for detection of biological pathogens (spores, viruses, bacteria) in complex aqueous samples. Our approach involves the combination of several novel technologies for enhancing thesensitivity, specificity, and dynamic range of biological warfare agent (BWA) detection. Integrated into a single assay, these novel components comprise a versatile platform technology that, in principle, is compatible with any fluorescent tag,recognition/binding element (e.g., antibodies, aptamers), biological entity (pathogens, proteins, DNA, etc.), and sample preparation method. The proposed assay will provide high density multiplexing, namely the ability to perform multiple assays in asingle sample, thus reducing both sample volumes and reagent consumption, and provide a greater degree of statistical reliability, especially for forensic applications. The Phase I results demonstrated proof-of-principle for the individual assaycomponents. In this proposal we detail the synthetic and formulation methods that will be used to produce and integrate the optimized assay components, and describe the methods that will be used to characterize the pathogen detection characteristics ofthe assay. The proposed pathogen assay will contribute to the protection of military and civilian personnel from biological attack, and serve as an analytical tool for forensic investigations. The technology has broad applications in the commercial sectorfor clinical diagnostic and prognostic assays and tools for pharmaceutical development.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
1,763 SBIR/STTR records share this UEI (1983–2026). Reported award amounts total $698,949,224. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, Department of Energy, National Science Foundation, Environmental Protection Agency
Agency intelligence
Department of Defense
Back to SBIR/STTR Research Awards